FY2025 · period end Oct '25 · from the 10-K filed Dec 17, 2025
| Metric | FY25Oct '25 | FY24Oct '24 | FY23Oct '23 | FY22Oct '22 | FY21Oct '21 |
|---|---|---|---|---|---|
| Revenue | $2.79B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0000072331-26-000034 | Jun 2, 2026 | Jun 3, 2026 | Jun 3, 2026 12:51 UTC | EDGAR |
| 10-Q | 0000072331-26-000024 | Apr 30, 2026 | May 21, 2026 | May 21, 2026 14:06 UTC | EDGAR |
| 8-K | 0000072331-26-000022 | May 20, 2026 | May 20, 2026 | May 20, 2026 20:33 UTC | EDGAR |
| 8-K | 0000072331-26-000017 | Mar 2, 2026 | Mar 4, 2026 | Mar 4, 2026 21:18 UTC | EDGAR |
| 10-Q | 0000072331-26-000014 | Jan 31, 2026 | Feb 19, 2026 | Feb 19, 2026 19:16 UTC | EDGAR |
| 8-K | 0000072331-26-000011 | Feb 18, 2026 | Feb 18, 2026 | Feb 18, 2026 21:31 UTC | EDGAR |
| 8-K | 0000072331-26-000005 | Jan 30, 2026 | Feb 2, 2026 | Feb 2, 2026 21:28 UTC | EDGAR |
| 10-K | 0000072331-25-000144 | Oct 31, 2025 | Dec 17, 2025 | Dec 17, 2025 21:35 UTC | EDGAR |
Direct links to SEC EDGAR. NDSN has additional filings available on the SEC site.
Figures a later SEC filing revised from what was first reported. Each diff compares the same XBRL tag across two filings — both linked, so you can check it yourself.
Income (Loss) from Continuing Operations before Income Taxes, Domestic·FY 2020
Notable restatementwas$120.1M
Revised down in a 10-K.
Income (Loss) from Continuing Operations before Income Taxes, Foreign·FY 2020
Notable restatementwas$181.4M
Revised up in a 10-K.
Income (Loss) from Continuing Operations before Income Taxes, Foreign·FY 2021
Notable restatementwas$286.8M
Revised up in a 10-K.
Income (Loss) from Continuing Operations before Income Taxes, Domestic·FY 2021
Notable restatementwas$287.4M
Revised down in a 10-K.
Operating Income (Loss)·FY 2017
Minor restatementwas$457.7M
Revised up in a 10-K.
Operating Income (Loss)·Q2 2018
Minor restatementwas$126.7M
Revised up in a 10-Q.
NDSN is not the only one.
See every restatement we've found across the market — or get an alert the next time NDSN revises a number.
Restatements are detected by comparing every vintage of a fact across all of NORDSON CORP's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows NDSN's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling NORDSON CORP — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on NDSN yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on NDSN and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $2.63B |
| $2.59B |
| $2.36B |
| Gross Profit | $1.54B | $1.49B | $1.43B | $1.43B | $1.32B |
|---|
| Operating Income | $0.71B | $0.67B | $0.67B | $0.70B | $0.62B |
|---|
| Net Income | $0.48B | $0.47B | $0.49B | $0.51B | $0.45B |
|---|
| EPS (Diluted) | $8.51 | $8.11 | $8.46 | $8.81 | $7.74 |
|---|
| Metric | FY25Oct '25 | FY24Oct '24 | FY23Oct '23 | FY22Oct '22 | FY21Oct '21 |
|---|---|---|---|---|---|
| Total Assets | $5.92B | $6.00B | $5.25B | $3.82B | $3.79B |
| Total Liabilities | — | — | — | — | — |
| Stockholders' Equity | $3.04B | $2.93B | $2.60B | $2.29B | $2.16B |
| Cash & Equivalents | $0.11B | $0.12B | $0.12B | $0.16B | $0.30B |
| Total Debt | $2.00B | $2.22B | $1.75B | $0.74B | $0.82B |
| Metric | FY25Oct '25 | FY24Oct '24 | FY23Oct '23 | FY22Oct '22 | FY21Oct '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $0.72B | $0.56B | $0.64B | $0.51B | $0.55B |
| Capital Expenditures | $0.06B | $0.06B | $0.03B | $0.05B | $0.04B |
| Free Cash Flow | $0.66B | $0.49B | $0.61B | $0.46B | $0.51B |
| Metric | FY25Oct '25 | FY24Oct '24 | FY23Oct '23 | FY22Oct '22 | FY21Oct '21 |
|---|---|---|---|---|---|
| Gross Margin | 55.2% | 55.2% | 54.2% | 55.1% | 56.1% |
| Operating Margin | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% |
| Net Margin | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% |
| Return on Equity | 16.2% | 16.9% | 19.9% | 23.0% | 23.2% |
| Return on Assets | 8.1% | 8.3% | 10.7% | 13.5% | 12.2% |
| Debt / Equity | 0.66× | 0.76× | 0.67× | 0.32× | 0.38× |
